2023
412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020
Kim D, Yousey-Hindes K. 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020. Open Forum Infectious Diseases 2023, 10: ofad500.482. PMCID: PMC10679268, DOI: 10.1093/ofid/ofad500.482.Peer-Reviewed Original ResearchAcute respiratory distress syndromeAge groupsFluSurv-NETRespiratory failureMedian lengthDischarge diagnosisPneumonia casesChest X-ray/CTIntensive care unit admissionEmerging Infections ProgramAcute respiratory failureCare unit admissionLaboratory-confirmed influenzaChronic lung diseaseRespiratory distress syndromeLonger median lengthCoronavirus disease 2019 (COVID-19) pandemicLength of stayChronic metabolic diseaseComparison of outcomesCOVID-19 hospitalizationHospitalized COVID-19COVID-19Disease 2019 pandemicSame age group740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
Jackson K, Resler S, Nadle J, Petit S, Yousey-Hindes K, Ray S, Lynfield R, Como-Sabetti K, Bernu C, Dumyati G, Tracy M, Schaffner W, Patel K, Havers F, Biggs H, See I, See I. 740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020. Open Forum Infectious Diseases 2023, 10: ofad500.801. PMCID: PMC10677147, DOI: 10.1093/ofid/ofad500.801.Peer-Reviewed Original ResearchCOVID-19-associated hospitalizationLong-term acute care hospitalLong-term care facilitiesCentral venous cathetersMultivariable logistic regressionAcute care hospitalsVenous cathetersCare hospitalCare facilitiesISA infectionsCDC's Emerging Infections ProgramIntensive care unit admissionLogistic regressionInvasive Staphylococcus aureus infectionsEmerging Infections ProgramSurveillance area residentCare unit admissionIntensive care interventionsBody mass indexIntensive care unitStaphylococcus aureus infectionInvasive Staphylococcus aureusBackground COVID-19Grant/research supportHigh death rate
2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials
Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine 2015, 33: 6241-6249. PMID: 26450660, PMCID: PMC4702247, DOI: 10.1016/j.vaccine.2015.09.078.Peer-Reviewed Original ResearchConceptsEmerging Infections ProgramHigh-risk groupRisk groupsRisk scoreIndex hospitalizationHospital dischargeDerivation cohortVaccine trialsValidation cohortDifficile infectionCox proportional hazards modelRisk of CDIAcute care hospitalizationIdentification of patientsClostridium difficile infectionHospital discharge dataNumber of hospitalizationsLow-risk groupProportional hazards modelLarge academic centerAdmission diagnosisPrimary outcomeInpatient stayPatient populationPharmacy data
2014
Impact of requiring influenza vaccination for children in licensed child care or preschool programs--Connecticut, 2012-13 influenza season.
Hadler JL, Yousey-Hindes K, Kudish K, Kennedy ED, Sacco V, Cartter ML. Impact of requiring influenza vaccination for children in licensed child care or preschool programs--Connecticut, 2012-13 influenza season. MMWR Morbidity And Mortality Weekly Report 2014, 63: 181-5. PMID: 24598593, PMCID: PMC4584725.Peer-Reviewed Original ResearchConceptsInfluenza-associated hospitalization ratesEmerging Infections ProgramInfluenza seasonHospitalization ratesVaccination ratesInfluenza transmissionSevere influenza-related illnessInfluenza-related illnessInfluenza-associated hospitalizationsLicensed child care programsOverall population rateGreater percentage decreaseCare admissionInfluenza vaccinationInfluenza vaccineSerious morbiditySusceptible childrenVaccination levelsInfections ProgramVaccination dataCare settingsEIP sitesCare programConnecticut childrenSurveillance sites
2011
Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005–2009
Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Bennett NM, Zansky S, Thomas A, Schaffner W, Fry AM. Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005–2009. The Journal Of Infectious Diseases 2011, 204: 1848-1856. PMID: 22013219, DOI: 10.1093/infdis/jir648.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAmantadineAntiviral AgentsDrug Therapy, CombinationFemaleGuideline AdherenceHospitalizationHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMaleMiddle AgedOdds RatioOseltamivirPandemicsPractice Guidelines as TopicPractice Patterns, Physicians'PregnancyPregnancy Complications, InfectiousRimantadineUnited StatesYoung AdultZanamivirConceptsAntiviral treatmentPregnant womenHospitalized adultsActive population-based surveillanceEmerging Infections ProgramLaboratory-confirmed influenzaMedical record reviewPopulation-based surveillanceAntiviral recommendationsAntiviral useRecord reviewIllness onsetInfections ProgramInfluenza pandemicAntiviral agentsInfluenzaNegative predictorAdultsTreatmentWomenPandemicPatientsPregnancyCliniciansPersons